Add to ORKGWhen histocompatibility differences exist between donor and recipient, it is necessary to modify or suppress the immune response in order to enable the recipient to accept a graft. Immunesuppressive therapy, in general, suppresses all immune responses, including those to bacteria, fungi and even malignant tumors. In the 1950s when clinical renal transplantation began, sublethal total body irradiation was employed. Currently immunosuppression is more safely induced pharmacologically. Agents used in humans to suppress the immune response are discussed in our paper
Objective: The purpose of this work was to perfonn kidney transplantation under a regimen of immunos...
Multidrug immunosuppressive protocols have increased short-term patient and graft survival rates fro...
Although the use of new immunosuppressive drugs, and their combination have drastically reduced the ...
mmunosuppressive treatment minimizes unwanted immune reactivity, but it also leads to complications ...
The immune system recognises a transplanted kidney as foreign body and mounts immune response throug...
In practical terms, regardless of HLA compatibility level, whenever tissues are transplanted from on...
Seeking to develop immunosuppression regimens that would take into account the patient's level of se...
The authors provide a historical survey of the immunosuppressive agents that have been used to preve...
In the second half of the 20th century, the transplantation of replacement organs and tissues to cur...
New classes of agents have sequentially increased the specificity of post-transplant immunosuppressi...
Suppression of allograft rejection is the central issue in renal transplantation (RT). Thus, develop...
Kidney transplantation remains the best therapeutic option for patients with end-stage renal disease...
For most patients with chronic kidney failure, kidney transplantation has the greatest potential for...
Background. The optimal reduction of immunosuppressive therapy (IST) in renal transplant patients wi...
Incidence of cardiovascular complications, cancers and chronic allograft nephropathy (CAN) suggests ...
Objective: The purpose of this work was to perfonn kidney transplantation under a regimen of immunos...
Multidrug immunosuppressive protocols have increased short-term patient and graft survival rates fro...
Although the use of new immunosuppressive drugs, and their combination have drastically reduced the ...
mmunosuppressive treatment minimizes unwanted immune reactivity, but it also leads to complications ...
The immune system recognises a transplanted kidney as foreign body and mounts immune response throug...
In practical terms, regardless of HLA compatibility level, whenever tissues are transplanted from on...
Seeking to develop immunosuppression regimens that would take into account the patient's level of se...
The authors provide a historical survey of the immunosuppressive agents that have been used to preve...
In the second half of the 20th century, the transplantation of replacement organs and tissues to cur...
New classes of agents have sequentially increased the specificity of post-transplant immunosuppressi...
Suppression of allograft rejection is the central issue in renal transplantation (RT). Thus, develop...
Kidney transplantation remains the best therapeutic option for patients with end-stage renal disease...
For most patients with chronic kidney failure, kidney transplantation has the greatest potential for...
Background. The optimal reduction of immunosuppressive therapy (IST) in renal transplant patients wi...
Incidence of cardiovascular complications, cancers and chronic allograft nephropathy (CAN) suggests ...
Objective: The purpose of this work was to perfonn kidney transplantation under a regimen of immunos...
Multidrug immunosuppressive protocols have increased short-term patient and graft survival rates fro...
Although the use of new immunosuppressive drugs, and their combination have drastically reduced the ...